Evaluating the Cost-Utility of Intestinal Resection Before Anti-Tumor Necrosis Factor Therapy for Strictures in Crohn's Disease in China

被引：0
|
作者：
Tang, X. [1 ]
Bai, X. [1 ]
Yang, H. [1 ]
Han, W. [2 ]
机构：
[1] Peking Union Med Coll & Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Gastroenterol, Beijing, Peoples R China
[2] Chinese Acad Med Sci, Dept Epidemiol & Biostat, Inst Basic Med Sci, School Basic Med,Peking Union Med Coll, Beijing, Peoples R China
来源：
JOURNAL OF CROHNS & COLITIS | 2025年 / 19卷
关键词：
D O I：
10.1093/ecco-jcc/jjae190.1368
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P1194
引用
收藏
页码：i2169 / i2169
页数：1
相关论文
共 50 条
  • [1] Anti-Tumor Necrosis Factor Therapy in Intestinal Behcet's Disease
    Park, Jihye
    Cheon, Jae Hee
    GUT AND LIVER, 2018, 12 (06) : 623 - 632
  • [2] Rates of tuberculosis infection in Crohn's Disease patients before and during anti-tumor necrosis factor therapy
    Georgieva, A. C.
    Atanassova, A.
    Mirchev, M.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I410 - I411
  • [3] Rates of tuberculosis infection in Crohn's Disease patients before and during anti-tumor necrosis factor therapy
    Georgieva, A. C.
    Atanassova, A.
    Mirchev, M.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I410 - I411
  • [4] Demyelination during anti-tumor necrosis factor α therapy with infliximab for Crohn's disease
    Thomas, CW
    Weinshenker, BG
    Sandborn, WJ
    INFLAMMATORY BOWEL DISEASES, 2004, 10 (01) : 28 - 31
  • [5] Effectiveness and Safety of lmmunomodulators With Anti-Tumor Necrosis Factor Therapy in Crohn's Disease
    Osterman, Mark T.
    Haynes, Kevin
    Delzell, Elizabeth
    Zhang, Jie
    Bewtra, Meenakshi
    Brensinger, Colleen M.
    Chen, Lang
    Xie, Fenglong
    Curtis, Jeffrey R.
    Lewis, James D.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (07) : 1293 - +
  • [6] Use of Vitamin D With Anti-Tumor Necrosis Factor Therapy for Crohn's Disease
    Bafutto, Mauro
    Oliveira, Enio Chaves
    Rezende Filho, Joffre
    GASTROENTEROLOGY RESEARCH, 2020, 13 (03) : 101 - 106
  • [7] Retreatment with anti-tumor necrosis factor therapy in combination with an immunomodulator for recurrence of Crohn's disease after ileocecal resection results in prolonged continuation as compared to anti-tumor necrosis factor monotherapy
    Huinink, Sebastiaan Ten Bokkel
    Beelen, Evelien M. J.
    Huinink, Thomas Ten Bokkel
    Hoentjen, Frank
    Bodelier, Alexander G. L.
    Dijkstra, Gerard
    Romberg-Camps, Marielle
    de Boer, Nanne K. K.
    Stassen, Laurents P. S.
    van der Meulen, Andrea E. E.
    West, Rachel
    van Ruler, Oddeke
    van der Woude, C. Janneke
    de Vries, Annemarie C. C.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2023, 35 (01) : 45 - 51
  • [8] Psoriasis during anti-tumor necrosis factor-alpha therapy for Crohn's disease
    Umeno, Junji
    Matsumoto, Takayuki
    Jo, Yukihiko
    Ichikawa, Miki
    Urabe, Kazunori
    Lida, Mitsuo
    INFLAMMATORY BOWEL DISEASES, 2007, 13 (09) : 1188 - 1189
  • [9] A safety assessment of anti-tumor necrosis factor alpha therapy for treatment of Crohn's disease
    Papamichael, Konstantinos
    Mantzaris, Gerassimos J.
    Peyrin-Biroulet, Laurent
    EXPERT OPINION ON DRUG SAFETY, 2016, 15 (04) : 493 - 501
  • [10] Anti-Tumor Necrosis Factor Therapy to Prevent Crohn's Disease Recurrence After Surgery
    Herfarth, Hans H.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2014, 12 (09) : 1503 - 1506
12345